Elevated funding in progressive know-how, options to ease workforce challenges and rising curiosity in residence care all symbolize key funding developments for healthcare in 2022 in accordance with a KPMG report printed Jan. 25.
To provide the 2022 Healthcare and Life Sciences Funding Outlook survey, accounting agency KPMG spoke to over 300 leaders within the healthcare and life sciences sectors. The respondents make clear how political adjustments, COVID-19 and market forces may change the outlook for investments in 2022.
Eight key findings:
- In 2021, healthcare know-how was second solely to hospital and well being programs by way of deal quantity, with 290 offers. Center-office programs, shopper engagement and telehealth had been all standard deal focuses.
- The whole deal worth for medical gadgets stood at $79 billion in 2021, with deal quantity growing by 13 p.c in comparison with 2020.
- A significant theme driving medical machine offers is innovation. Many corporations want to form their portfolios with new applied sciences like sensible gadgets or synthetic intelligence- powered platforms.
- About 75 p.c of respondents instructed KPMG that well being IT deal exercise had surpassed their expectations.
- Probably the most enticing funding choices for the following 12 to 24 months had been cited as digital well being, EHRs and scientific workflow options. This may increasingly level to the pressing want for well being programs to ease staffing points and combine applied sciences that may assist with workflow points.
- Waiting for well being IT offers this yr, one respondent stated, “We count on one of many subsequent frontiers to be offers that assist join knowledge throughout apps, applications, platforms, digital well being data, and, finally, well being programs.
- Massive well being programs want to fund innovation facilities and incubation hubs to drive growth of recent applied sciences. Hospitals will proceed to spend money on such new know-how as distant affected person know-how, knowledge analytics and telehealth.
- Investments in residence and hospice care are anticipated to extend in 2022. Acquisitions within the sector elevated 28 p.c from 2020 to 2021. The sector can count on rising demand pushed by affected person choice and procedures delayed by COVID-19.